Pay in 4 interest-free payments of $21.25 Learn more
Ships within 48 hours · Estimated delivery Jul 29 - Aug 3
3-dihydropyridazine-4-carboxamide
Chemical Name: 3-(4-methoxypyridine-3-carbonyl)-1-[2-(trifluoromethyl)-[1
with a pharmacokinetic profile enabling long-acting drug efficacy
It is noteworthy that the effect of VX 765 on the release of IL-1β induced by LPS reached a plateau at 100 mg/kg
BMS-345541 is also found to override the spindle checkpoint in nocodazole-arrested cells
Saxagliptin hydrate esceinamine Isomer II 3-dihydropyridazine-4-carboxamideSaxagliptin, also known as BMS 477118, is a new oral hypoglycemic (anti diabetic drug) of the new dipeptidyl peptidase 4 (DPP 4) inhibitor class of drugs. Saxagliptin was approved in 2008 for the treatment of type 2 diabetes. Saxagliptin is a competitive DPP4 inhibitor that slows the inactivation of the incretin hormones, thereby increasing their bloodstream concentrations and reducing fasting and postprandial glucose concentrations in a glucose